Trial intelligence / Profile preview

Daclatasvir and Asunaprevir in Real-World Chronic Hepatitis C

NCT02639585Phase 4Unknown

Sponsor
Pusan National University Hospital
Start
Dec 2015
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of daclatasvir, asunaprevir in hepatitis C (HCV), sponsored by Pusan National University Hospital. Status: unknown.

02

Drugs

daclatasvirasunaprevir
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT02639585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02639585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call